GR3036542T3 - N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate - Google Patents

N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate

Info

Publication number
GR3036542T3
GR3036542T3 GR20010401324T GR20010401324T GR3036542T3 GR 3036542 T3 GR3036542 T3 GR 3036542T3 GR 20010401324 T GR20010401324 T GR 20010401324T GR 20010401324 T GR20010401324 T GR 20010401324T GR 3036542 T3 GR3036542 T3 GR 3036542T3
Authority
GR
Greece
Prior art keywords
piperazinyl
acetyl
pct
fluorobenzamide
date jun
Prior art date
Application number
GR20010401324T
Other languages
English (en)
Inventor
Satoshi Kitamura
Hisashi Mimura
Hiroshi Yamasaki
Yukihisa Baba
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of GR3036542T3 publication Critical patent/GR3036542T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GR20010401324T 1996-12-12 2001-09-06 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate GR3036542T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33178496 1996-12-12
PCT/JP1997/004451 WO1998025914A1 (en) 1996-12-12 1997-12-05 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate

Publications (1)

Publication Number Publication Date
GR3036542T3 true GR3036542T3 (en) 2001-12-31

Family

ID=18247607

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401324T GR3036542T3 (en) 1996-12-12 2001-09-06 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate

Country Status (20)

Country Link
US (1) US6147079A (el)
EP (1) EP0944612B1 (el)
JP (1) JP3254683B2 (el)
KR (1) KR20000057342A (el)
CN (1) CN1073104C (el)
AT (1) ATE205198T1 (el)
AU (1) AU722095B2 (el)
CA (1) CA2274682A1 (el)
DE (1) DE69706562T2 (el)
DK (1) DK0944612T3 (el)
EA (1) EA001715B1 (el)
ES (1) ES2160371T3 (el)
GR (1) GR3036542T3 (el)
HK (1) HK1024482A1 (el)
HU (1) HUP0002975A3 (el)
IL (1) IL130273A (el)
PT (1) PT944612E (el)
TW (1) TW422844B (el)
WO (1) WO1998025914A1 (el)
ZA (1) ZA9710872B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1109025C (zh) * 1997-10-09 2003-05-21 藤泽药品工业株式会社 氨基哌嗪衍生物的新制造法
AUPP818099A0 (en) * 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
US6344358B1 (en) 1999-05-28 2002-02-05 Fujisawa Pharmaceutical Co., Ltd. Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
GB0021885D0 (en) * 2000-09-06 2000-10-18 Fujisawa Pharmaceutical Co New use
WO2002034735A1 (fr) * 2000-10-23 2002-05-02 Fujisawa Pharmaceutical Co., Ltd. Procede de preparation d'un solvate et solvate
EP1340499A4 (en) * 2000-12-07 2006-05-03 Astellas Pharma Inc MEANS FOR REINFORCING THE NOOTROPIC EFFECT
EP1498126A1 (en) * 2002-04-10 2005-01-19 Fujisawa Pharmaceutical Co., Ltd. Neurotrophic factor production accelerator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
US5250528A (en) * 1989-08-02 1993-10-05 Fujisawa Pharmaceutical Co., Ltd. New aminopiperazine derivatives

Also Published As

Publication number Publication date
ZA9710872B (en) 1998-06-15
ATE205198T1 (de) 2001-09-15
DE69706562T2 (de) 2002-05-29
TW422844B (en) 2001-02-21
ES2160371T3 (es) 2001-11-01
CA2274682A1 (en) 1998-06-18
JP2000514460A (ja) 2000-10-31
EA001715B1 (ru) 2001-08-27
EP0944612B1 (en) 2001-09-05
HUP0002975A2 (hu) 2001-12-28
KR20000057342A (ko) 2000-09-15
AU5136898A (en) 1998-07-03
HUP0002975A3 (en) 2002-01-28
HK1024482A1 (en) 2000-10-13
EA199900530A1 (ru) 1999-12-29
DE69706562D1 (de) 2001-10-11
AU722095B2 (en) 2000-07-20
EP0944612A1 (en) 1999-09-29
IL130273A (en) 2003-05-29
WO1998025914A1 (en) 1998-06-18
CN1073104C (zh) 2001-10-17
CN1245495A (zh) 2000-02-23
JP3254683B2 (ja) 2002-02-12
US6147079A (en) 2000-11-14
DK0944612T3 (da) 2001-11-19
IL130273A0 (en) 2000-06-01
PT944612E (pt) 2002-01-30

Similar Documents

Publication Publication Date Title
DE69531457D1 (en) Sulfonamide
GB9406857D0 (en) Improvements in or relating to organic compounds
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
IL116231A0 (en) Dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ZA9710872B (en) N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate.
IL122894A (en) Fungicidal mixtures
MY112944A (en) Enterokinetic benzamide
AU2534595A (en) Angiotensin ii for improving fertilization
JPS56501648A (el)
GR3005736T3 (el)
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
MX9606295A (es) Tiopiridinas para el combate de bacterias heliobacter.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
CZ145095A3 (en) Novel triazoloquinazolines, process of their preparation and use
HUT76271A (en) Substituted aminoalkylaminopyridines, process for producing them and their use
ATE189391T1 (de) Verwendung von lithiumverbindungen zur behandlung und prophylaxe des morbus alzheimer
MY128749A (en) Fungicidal mixtures
PT94432A (pt) Processo para a producao sulfonamidas substituidas e compostos afins uteis no tratamento da asma, artrite e doencas afins

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees